Real-world efficacy and safety of 8 mg aflibercept in neovascular AMD: a case series
Objective This real-world retrospective case series evaluates the safety and efficacy of aflibercept 8 mg in patients diagnosed with neovascular age-related macular degeneration (nAMD).Methods and analyses Treatment-naïve or treatment-experienced patients with nAMD receiving aflibercept 8 mg with at...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-02-01
|
| Series: | BMJ Open Ophthalmology |
| Online Access: | https://bmjophth.bmj.com/content/10/1/e002091.full |